Cite
MLA Citation
Nirali N. Shah et al.. “Results from an international phase 2 study of the anti‐CD22 immunotoxin moxetumomab pasudotox in relapsed or refractory childhood B‐lineage acute lymphoblastic leukemia.” Pediatric blood & cancer, vol. 67, no. 5, 2020, p. n/a. http://access.bl.uk/ark:/81055/vdc_100102664674.0x000023